Nasal Polyps Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1066946
  • May 2021
  • Pharmaceuticals
  • 144 Pages
The global Nasal Polyps Treatment market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Nasal Polyps Treatment market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Nasal Polyps Treatment market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Nasal Polyps Treatment market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered OptiNose US, Inc., Regeneron Pharmaceuticals, Inc., Merck KGaA, Pfizer, Inc., F. Hoffmann La-Roche, Ltd., Intersect ENT, Inc., GlaxoSmithKline plc, Novartis, Sanofi, Taro Pharmaceutical Industries Ltd.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Nasal Polyps Treatment market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Nasal Polyps Treatment market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Nasal Polyps Treatment market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Nasal Polyps Treatment market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Nasal Polyps Treatment Market:
The Nasal Polyps Treatment market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. OptiNose US, Inc., Regeneron Pharmaceuticals, Inc., Merck KGaA, Pfizer, Inc., F. Hoffmann La-Roche, Ltd., Intersect ENT, Inc., GlaxoSmithKline plc, Novartis, Sanofi, Taro Pharmaceutical Industries Ltd.

Nasal Polyps Treatment Market Segment Analysis:
by Treatment Type
Corticosteroids
Antibiotics
Leukotriene Inhibitors
Others
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies and Geopgraphy

Geographic Coverage for Nasal Polyps Treatment Market:
The market research report on global Nasal Polyps Treatment market offers complete analysis across various regions across the world. The Nasal Polyps Treatment market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Nasal Polyps Treatment market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Nasal Polyps Treatment Market Value and Forecast
  • US
  • Canada
Europe Nasal Polyps Treatment Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Nasal Polyps Treatment Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Nasal Polyps Treatment Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Nasal Polyps Treatment Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Nasal Polyps Treatment market report:
  • The report provides key trends of the global Nasal Polyps Treatment market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Nasal Polyps Treatment industry
  • The report covers all the recent developments of the Nasal Polyps Treatment market and helps to provide current industry updates
  • The report covers a detailed look over the global Nasal Polyps Treatment Industry and provides with significant actionable insights
  • The Nasal Polyps Treatment market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Nasal Polyps Treatment market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Nasal Polyps Treatment market
  • Comprehensive analysis of the Nasal Polyps Treatment market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Nasal Polyps Treatment market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Nasal Polyps Treatment market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Nasal Polyps Treatment market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Nasal Polyps Treatment market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Nasal Polyps Treatment market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • OptiNose US, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Merck KGaA
  • Pfizer, Inc.
  • F. Hoffmann La-Roche, Ltd.
  • Intersect ENT, Inc.
  • GlaxoSmithKline plc
  • Novartis
  • Sanofi
  • Taro Pharmaceutical Industries Ltd.
  • Corticosteroids
  • Antibiotics
  • Leukotriene Inhibitors
  • Others
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online PharmaciesGeopgraphy

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Nasal Polyps Treatment Market Snapshot
          2.1.1. Global Nasal Polyps Treatment Market By Treatment Type,2019
               2.1.1.1.Corticosteroids
               2.1.1.2.Antibiotics
               2.1.1.3.Leukotriene Inhibitors
               2.1.1.4.Others
          2.1.2. Global Nasal Polyps Treatment Market By Distribution Channel,2019
               2.1.2.1.Hospital Pharmacies
               2.1.2.2.Retail Pharmacies
               2.1.2.3.Online PharmaciesGeopgraphy
          2.1.3. Global Nasal Polyps Treatment Market By End-use,2019
          2.1.4. Global Nasal Polyps Treatment Market By Geography,2019

3. Global Nasal Polyps Treatment Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Nasal Polyps Treatment Market Size (US$), By Treatment Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Treatment Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Treatment Type, 2020
     4.2. Global Nasal Polyps Treatment Market Size (US$), By Treatment Type, 2018 – 2028

5. Global Nasal Polyps Treatment Market Size (US$), By Distribution Channel, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Distribution Channel, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Distribution Channel, 2020
     5.2. Global Nasal Polyps Treatment Market Size (US$), By Distribution Channel, 2018 – 2028

6. Global Nasal Polyps Treatment Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Nasal Polyps Treatment Market Size (US$), By End-use, 2018 – 2028

7. Global Nasal Polyps Treatment Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Nasal Polyps Treatment Market Analysis, 2018 – 2028 
          7.2.1. North America Nasal Polyps Treatment Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Nasal Polyps Treatment Market Size (US$), By Treatment Type, 2018 – 2028
          7.2.3. North America Nasal Polyps Treatment Market Size (US$), By Distribution Channel, 2018 – 2028
          7.2.4. North America Nasal Polyps Treatment Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Nasal Polyps Treatment Market Analysis, 2018 – 2028 
          7.3.1.  Europe Nasal Polyps Treatment Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Nasal Polyps Treatment Market Size (US$), By Treatment Type, 2018 – 2028
          7.3.3. Europe Nasal Polyps Treatment Market Size (US$), By Distribution Channel, 2018 – 2028
          7.3.4. Europe Nasal Polyps Treatment Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Nasal Polyps Treatment Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Nasal Polyps Treatment Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Nasal Polyps Treatment Market Size (US$), By Treatment Type, 2018 – 2028
          7.4.3. Asia Pacific Nasal Polyps Treatment Market Size (US$), By Distribution Channel, 2018 – 2028
          7.4.4. Asia Pacific Nasal Polyps Treatment Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Nasal Polyps Treatment Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Nasal Polyps Treatment Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Nasal Polyps Treatment Market Size (US$), By Treatment Type, 2018 – 2028
          7.5.3. Latin America Nasal Polyps Treatment Market Size (US$), By Distribution Channel, 2018 – 2028
          7.5.4. Latin America Nasal Polyps Treatment Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Nasal Polyps Treatment Market Analysis, 2018 – 2028 
          7.6.1.  MEA Nasal Polyps Treatment Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Nasal Polyps Treatment Market Size (US$), By Treatment Type, 2018 – 2028
          7.6.3. MEA Nasal Polyps Treatment Market Size (US$), By Distribution Channel, 2018 – 2028
          7.6.4. MEA Nasal Polyps Treatment Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Nasal Polyps Treatment Providers
        8.4.1 OptiNose US, Inc.
                8.4.1.1 Business Description
                8.4.1.2 OptiNose US, Inc. Geographic Operations
                8.4.1.3 OptiNose US, Inc. Financial Information
                8.4.1.4 OptiNose US, Inc. Product Positions/Portfolio
                8.4.1.5 OptiNose US, Inc. Key Developments
        8.4.2 Regeneron Pharmaceuticals, Inc.
                8.4.2.1 Business Description
                8.4.2.2 Regeneron Pharmaceuticals, Inc. Geographic Operations
                8.4.2.3 Regeneron Pharmaceuticals, Inc. Financial Information
                8.4.2.4 Regeneron Pharmaceuticals, Inc. Product Positions/Portfolio
                8.4.2.5 Regeneron Pharmaceuticals, Inc. Key Developments
        8.4.3 Merck KGaA
                8.4.3.1 Business Description
                8.4.3.2 Merck KGaA Geographic Operations
                8.4.3.3 Merck KGaA Financial Information
                8.4.3.4 Merck KGaA Product Positions/Portfolio
                8.4.3.5 Merck KGaA Key Developments
        8.4.4 Pfizer, Inc.
                8.4.4.1 Business Description
                8.4.4.2 Pfizer, Inc. Geographic Operations
                8.4.4.3 Pfizer, Inc. Financial Information
                8.4.4.4 Pfizer, Inc. Product Positions/Portfolio
                8.4.4.5 Pfizer, Inc. Key Developments
        8.4.5 F. Hoffmann La-Roche, Ltd.
                8.4.5.1 Business Description
                8.4.5.2 F. Hoffmann La-Roche, Ltd. Geographic Operations
                8.4.5.3 F. Hoffmann La-Roche, Ltd. Financial Information
                8.4.5.4 F. Hoffmann La-Roche, Ltd. Product Positions/Portfolio
                8.4.5.5 F. Hoffmann La-Roche, Ltd. Key Developments
        8.4.6 Intersect ENT, Inc.
                8.4.6.1 Business Description
                8.4.6.2 Intersect ENT, Inc. Geographic Operations
                8.4.6.3 Intersect ENT, Inc. Financial Information
                8.4.6.4 Intersect ENT, Inc. Product Positions/Portfolio
                8.4.6.5 Intersect ENT, Inc. Key Developments
        8.4.7 GlaxoSmithKline plc
                8.4.7.1 Business Description
                8.4.7.2 GlaxoSmithKline plc Geographic Operations
                8.4.7.3 GlaxoSmithKline plc Financial Information
                8.4.7.4 GlaxoSmithKline plc Product Positions/Portfolio
                8.4.7.5 GlaxoSmithKline plc Key Developments
        8.4.8 Novartis
                8.4.8.1 Business Description
                8.4.8.2 Novartis Geographic Operations
                8.4.8.3 Novartis Financial Information
                8.4.8.4 Novartis Product Positions/Portfolio
                8.4.8.5 Novartis Key Developments
        8.4.9 Sanofi
                8.4.9.1 Business Description
                8.4.9.2 Sanofi Geographic Operations
                8.4.9.3 Sanofi Financial Information
                8.4.9.4 Sanofi Product Positions/Portfolio
                8.4.9.5 Sanofi Key Developments
        8.4.10 Taro Pharmaceutical Industries Ltd.
                8.4.10.1 Business Description
                8.4.10.2 Taro Pharmaceutical Industries Ltd. Geographic Operations
                8.4.10.3 Taro Pharmaceutical Industries Ltd. Financial Information
                8.4.10.4 Taro Pharmaceutical Industries Ltd. Product Positions/Portfolio
                8.4.10.5 Taro Pharmaceutical Industries Ltd. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Nasal Polyps Treatment Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Nasal Polyps Treatment Market Revenue, By Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Nasal Polyps Treatment Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Nasal Polyps Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Nasal Polyps Treatment Market Revenue, By Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Nasal Polyps Treatment Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Nasal Polyps Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Nasal Polyps Treatment Market Revenue, By Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Nasal Polyps Treatment Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Nasal Polyps Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Nasal Polyps Treatment Market Revenue, By Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Nasal Polyps Treatment Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Nasal Polyps Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Nasal Polyps Treatment Market Revenue, By Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Nasal Polyps Treatment Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Nasal Polyps Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Nasal Polyps Treatment: Market Segmentation 
FIG. 2 Global Nasal Polyps Treatment Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Nasal Polyps Treatment Market, By Treatment Type, 2019 (US$ Mn) 
FIG. 5 Global Nasal Polyps Treatment Market, By Distribution Channel, 2019 (US$ Mn) 
FIG. 6 Global Nasal Polyps Treatment Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Nasal Polyps Treatment Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Nasal Polyps Treatment Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Nasal Polyps Treatment Providers, 2019
FIG. 11 Global Nasal Polyps Treatment Market Revenue Contribution, By Treatment Type, 2019 & 2028 (Value %) 
FIG. 12 Global Nasal Polyps Treatment Market Revenue Contribution, By Distribution Channel, 2019 & 2028 (Value %) 
FIG. 13 Global Nasal Polyps Treatment Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Nasal Polyps Treatment Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Nasal Polyps Treatment Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Nasal Polyps Treatment Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Nasal Polyps Treatment Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Nasal Polyps Treatment Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Nasal Polyps Treatment market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Nasal Polyps Treatment Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Nasal Polyps Treatment Market Value, By Segment1, 2018 – 2028
TABLE  North America Nasal Polyps Treatment Market Value, By Segment2, 2018 – 2028
TABLE  North America Nasal Polyps Treatment Market Value, By Country, 2018 – 2028
TABLE  Europe Nasal Polyps Treatment Market Value, By Segment1, 2018 – 2028
TABLE  Europe Nasal Polyps Treatment Market Value, By Segment2, 2018 – 2028
TABLE  Europe Nasal Polyps Treatment Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Nasal Polyps Treatment Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Nasal Polyps Treatment Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Nasal Polyps Treatment Market Value, By Country, 2018 – 2028
TABLE  Latin America Nasal Polyps Treatment Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Nasal Polyps Treatment Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Nasal Polyps Treatment Market Value, By Country, 2018 – 2028
TABLE  MEA Nasal Polyps Treatment Market Value, By Segment1, 2018 – 2028
TABLE  MEA Nasal Polyps Treatment Market Value, By Segment2, 2018 – 2028
TABLE  MEA Nasal Polyps Treatment Market Value, By Country, 2018 – 2028
TABLE  OptiNose US, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Regeneron Pharmaceuticals, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck KGaA: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  F. Hoffmann La-Roche, Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Intersect ENT, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novartis: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sanofi: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Taro Pharmaceutical Industries Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Nasal Polyps Treatment Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Nasal Polyps Treatment Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Nasal Polyps Treatment Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Nasal Polyps Treatment Market, By Geography, 2019 (US$ Mn)
FIG.  Global Nasal Polyps Treatment Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Nasal Polyps Treatment Providers, 2016
FIG.  Global Nasal Polyps Treatment Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Antibiotics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Leukotriene Inhibitors Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Nasal Polyps Treatment Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Retail Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Online PharmaciesGeopgraphy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Nasal Polyps Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Nasal Polyps Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Nasal Polyps Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Nasal Polyps Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Nasal Polyps Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Nasal Polyps Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Nasal Polyps Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Nasal Polyps Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Nasal Polyps Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Nasal Polyps Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Nasal Polyps Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Nasal Polyps Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Nasal Polyps Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Nasal Polyps Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Nasal Polyps Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Nasal Polyps Treatment Market Value, 2018 – 2028, (US$ Mn)